Cytoprotective signaling associated with nitric oxide upregulation in tumor cells subjected to photodynamic therapy-like oxidative stress

Free Radical Biology and Medicine

Volumn 57, Issue , 2013, Pages 39-48

  Bhowmick, Reshma ^a   Girotti, Albert W ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

Apoptosis; Free radicals; Nitric oxide; Photodynamic therapy; Stress resistance signaling

Indexed keywords

CYCLIC GMP; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; MITOGEN ACTIVATED PROTEIN KINASE P38 INHIBITOR; NITRIC OXIDE; STRESS ACTIVATED PROTEIN KINASE INHIBITOR; SURVIVIN; WORTMANNIN;

APOPTOSIS; ARTICLE; BREAST ADENOCARCINOMA; CARCINOMA CELL; CELL PROTECTION; ENZYME ACTIVATION; ENZYME INDUCTION; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; IMMUNOPRECIPITATION; INTRACELLULAR SIGNALING; OXIDATIVE STRESS; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SENSITIZATION; UPREGULATION; WESTERN BLOTTING;

ADENOCARCINOMA; AMINOLEVULINIC ACID; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; BREAST NEOPLASMS; CELL LINE, TUMOR; CYTOPROTECTION; ENZYME INHIBITORS; FEMALE; HUMANS; INHIBITOR OF APOPTOSIS PROTEINS; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MAP KINASE SIGNALING SYSTEM; NF-KAPPA B; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; NITRILES; OXIDATIVE STRESS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOTOCHEMOTHERAPY; PROTEIN TRANSPORT; PROTO-ONCOGENE PROTEINS C-AKT; REACTIVE OXYGEN SPECIES; RNA INTERFERENCE; RNA, SMALL INTERFERING; SULFONES;

POUTERIA SANDWICENSIS;

EID: 84872525706     PISSN: 08915849     EISSN: 18734596     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2012.12.005     Document Type: Article

References (56)

1. SR Moncada, RMJ Palmer, and EA. Higgs Nitric oxide: physiology, pathophysiology, and pharmacology Pharmacol Rev 43 1991 109 143
2. DA Wink, and JB. Mitchell Chemical biology of nitric oxide: insights into the regulatory, cytotoxic, and cytoprotective mechanisms of nitric oxide Free Radic Biol Med 25 1998 434 456 (Pubitemid 28390299)
3. DA Wink, HB Hines, RYS Cheng, CH Switzer, W Flores-Santana, and MP Vitek Nitric oxide redox mechanisms in the immune response J Leukoc Biol 89 2011 873 891
4. Y-M Kim, ME deVera, SC Watkins, and TR. Billiar Nitric oxide protects cultured rat hepatocytes from tumor necrosis factor-alpha-induced apoptotia by inducing heat shock protein-70 J Biol Chem 272 1997 1402 1411 (Pubitemid 27034647)
5. Y-M Kim, RV Talanian, and TR. Billiar Nitric oxide inhibits apoptosis by preventing increases in caspase-3-like activity via two distinct mechanisms J Biol Chem 272 1997 31138 31148 (Pubitemid 27527564)
6. Y-M Kim, H-T Chung, S-S Kim, J-A Han, Y-M Yoo, and K-M Kim Nitric oxide protects PC-12 cells from serum deprivation-induced apoptosis by cGMP-dependent inhibition of caspase signaling J.Neurosci 19 1999 6740 6747 (Pubitemid 29380102)
7. R Weller, A Schwentker, TR Billiar, and Y. Vodovotz Autologous nitric oxide protects mouse and human keratinocytes from ultraviolet B radiation-induced apoptosis Am J Physiol Cell Physiol 284 2003 C1140 C1148
8. D Fukumura, S Kashiwagi, and RK. Jain The role of nitric oxide in tumor progression Nat Rev Cancer 6 2006 521 534 (Pubitemid 43980541)
9. DA Wink, LA Ridnour, SP Hussain, and CC. Harris The reemergence of nitric oxide and cancer Nitric Oxide 19 2008 65 67 (Pubitemid 351970245)
10. BW Henderson, TM Sitnik-Busch, and LA. Vaughn Potentiation of photodynamic therapy antitumor activity in mice by nitric oxide synthase inhibition is fluence rate-dependent Photochem Photobiol 70 1999 64 71 (Pubitemid 129572616)
11. M Korbelik, CS Parkins, H Shibuya, I Cecic, MRL Stratford, and DJ. Chaplin Nitric oxide production by tumor tissue: impact on the response to photodynamic therapy Br J Cancer 82 2000 1835 1843 (Pubitemid 30307397)
12. KJ Reeves, MW Reed, and NJ. Brown The role of nitric oxide in the treatment of tumors with aminolevulinic acid-induced photodynamic therapy J Photochem Photobiol B 101 2010 224 232
13. R Bhowmick, and AW. Girotti Cytoprotective induction of nitric oxide synthase in a cellular model of 5-aminolevulinic acid-based photodynamic therapy Free Radic Biol Med 48 2010 1296-01
14. R Bhowmick, and AW. Girotti Rapid upregulation of cytoprotective nitric oxide in breast tumor cells subjected to a photodynamic therapy-like oxidative challenge Photochem Photobiol 87 2011 378 386
15. RS Esworthy, MA Baker, and F-F. Chu Expression of selenium-dependent glutathione peroxidase in human breast tumor cell lines Cancer Res 55 1995 957 962
16. R Hurst, W Korytowski, T Kriska, RS Esworthy, F-F Chu, and AW. Girotti Hyperresistance to cholesterol hydroperoxide-induced peroxidative injury and apoptotic death in a tumor cell line that overexpresses glutathione peroxidase isotype-4 Free Radic Biol Med 31 2001 1051 1065 (Pubitemid 33000127)
17. Q Peng, K Berg, J Moan, M Kongshaug, and JM. Nesland 5-Aminolevulinic acid-based photodynamic therapy; principles and experimental research Photochem Photobiol 65 1997 235 251 (Pubitemid 27158805)
18. M van Engeland, LJW Nieland, FC Ramaekers, B Schutte, and CP. Reutelingsperger Annexin V-affinity asay: a review on an apoptosis detection system based on phosphatidylserine exposure Cytometry 31 1998 1 9 (Pubitemid 28050057)
19. R Bhowmick, and AW. Girotti Signaling events in apoptotic photokilling of 5-aminolevulinic acid-treated tumor cells: inhibitory effects of nitric oxide Free Radic Biol Med 47 2009 731 740
20. NT Bui, A Livolsi, J-F Peyron, and JHM Prehn Activation of nuclear factor κB and bcl-x survival gene expression by nerve growth factor requires tyrosine phosphorylation of IκBα J Cell Biol 152 2001 753 763 (Pubitemid 34280160)
21. SM Abmayr, T Yao, T Parmely, and JL. Workman Preparation of nuclear and cytoplasmic extracts from mammalian cells Current Protocols in Molecular Biology 2006 1 10
22. Q-W Xie, Y Kashiwabara, and C. Nathan Role of transcription factor NF-κB/Rel in induction of nitric oxide synthase J Biol Chem 269 1994 4705 4708 (Pubitemid 24239438)
23. CJ Lowenstein, and E. Padalko iNOS (NOS2) at a glance J Cell Sci 117 2004 2865 2867 (Pubitemid 39117660)
24. RG Baker, MS Hayden, and S. Ghosh NF-κB, inflammation, and metabolic disease Cell Metabolism 13 2011 11 22
25. H-M Shen, and V. Tergaonkar NF-κB signaling in carcinogenesis and as a potential molecular target for cancer therapy Apoptosis 14 2009 348 363
26. F Hofmann, R Feil, T Kleppisch, and J. Schlossmann Function of cGMP-dependent protein kinases as revealed by gene deletion Physiol Rev 86 2006 1 23
27. M Fraser, SL Chan, SS Chan, RR Fiscus, and BK. Tsang Regulation of p53 and suppression of apoptosis by the soluble guanylyl cyclase/cGMP pathway in human ovarian cancer cells Oncogene 25 2006 2203 2212
28. ER Gomes, RD Almeida, AP Carvalho, and CB. Duarte Nitric oxide modulates tumor cell death induced by photodynamic therapy through a cGMP-dependent mechanism Photochem Photobiol 76 2002 423 430
29. KA Lucas, GM Pitari, S Kazerounian, I Ruiz-Stewart, J Park, and S Schulz Guanylyl cyclases and signaling by cyclic GMP Pharmacol Rev 52 2000 375-14
30. L Stephens, R Williams, and P. Hawkins Phosphoinositide 3-kinases as drug targets in cancer Curr Opin Pharmacol 5 2005 357 365 (Pubitemid 40932037)
31. L Keefer, RW Nims, and KM Davies Wink DA.NONOates (1-substituted diazen-1-ium-1,2-diolates) as nitric oxide donors: convenient nitric oxide dosage forma Methods Enzymol 268 1996 281 293
32. T Wada, and JM. Penninger Mitogen-activated protein kinases in apoptosis regulation Oncogene 23 2004 2838 2849 (Pubitemid 38638846)
33. A Porras, S Zuluaga, E Black, A Valladares, A Alvarez, and C Ambrosino p38α Mitogen-activated protein kinase sensitizes cells to apoptosis induced by different stimuli Mol Biol Cell 15 2004 922 933 (Pubitemid 38146504)
34. JS Fridman, and SW. Lowe Control of apoptosis by p53 Oncogene 22 2003 9030 9040 (Pubitemid 38121703)
35. DC. Altieri Survivin, cancer networks and pathway-directed drug discovery Nat. Rev. Cancer 8 2008 61 70
36. J De Alba, NM Clayton, SD Collins, P Colthup, I Chessell, and RG. Knowles GW274150, a novel and highly selective inhibitor of the inducible isoform of nitric oxide synthase (iNOS), shows analgesic effects in rat models of inflammatory and neuropathic pain Pain 120 2006 170 181 (Pubitemid 43077180)
37. D Singh, D Richards, RG Knowles, S Schwartz, A Woodcock, S Langley, and BJ. O'Connor Selective inducible nitric oxide synthase inhibition has no effect of allergen challenge in asthma Am J Respir Crit Care Med 176 2007 988 993 (Pubitemid 350127842)
38. WK Alderton, CE Cooper, and RG. Knowles Nitric oxide syhthases: structure, function and inhibition Biochem J 357 2001 593-15 (Pubitemid 32735142)
39. DA Wink, Y Vodovotz, J Laval, F Laval, MW Dewhirst, and JB. Mitchell The multifaceted roles of nitric oxide in cancer Carcinogenesis 19 1998 711 721 (Pubitemid 28376759)
40. JA Crowell, VE Steele, CC Sigman, and JR. Fay Is inducible nitric oxide synthase a target for chemoprevention? Mol Cancer Ther 2 2003 815 823
41. AG Sikora, A Gelbard, MA Davies, D Sano, S Ekmekcioglu, and J Kwon Targeted inhibition of inducible nitric oxide synthase inhibits growth of human melanoma in vivo and synergizes with chemotherapy Clin Cancer Res 16 2010 1834 1844
42. CE Eyler, Q Wu, K Yan, JM MacSwords, D Chandler-Militello, and KL Misuraca Glioma stem cell proliferation and tumor growth are promoted by nitric oxide synthase 2 Cell 146 2011 53 66
43. VH Fingar, and BW. Henderson Drug and light dose dependence of photodynamic therapy: a study of tumor and normal tissue response Photochem Photobiol 46 1987 837 841
44. B-H Jiang, and L-Z. Liu PI3K/PTEN signaling in tumorigenesis and angiogenesis Biochim Biophys Acta 1784 2008 150 158
45. M Saura Zaragoza C, Bao C, McMillan A, Lowenstein CJ. Interaction of interferon regulatory factor-1 and nuclear factor kappa B during activation of inducible nitric oxide synthase transcription J. Mol. Biol 289 1999 459 471 (Pubitemid 29295117)
46. MK Cho, SH Suh, and SG. Kim Jun B/AP-1 and NF-κB-mediated induction of nitric oxide synthase by bovine type I collagen in serum-stimulated murine macrophages Nitric Oxide 6 2002 319 332 (Pubitemid 34852376)
47. J Gao, DC Morrison, D Parmely, SW Russell, and WJ. Murphy An interferon-gamma-activated site (GAS) is necessary for full expression of the mouse iNOS gene in response to interferon-gamma and lipoxygenase J. Biol. Chem 272 1997 1226 1230 (Pubitemid 27034621)
48. A Ferrario, N Rucker, S Wong, M Luna, and Gomer.CJ Survivin a member of the inhibitor of apoptosis family, is induced by photodynamic therapy and is a target for improving treatment response Cancer Res 67 2007 4989 4995 (Pubitemid 46910208)
49. V Fetz, C Bier, N Habtemichael, R Schuon, A Schweitzer, and M Kunkel Inducible NO synthase confers chemoresistance in head and neck cancer by modulating survivin Int J Cancer 124 2009 2033 2041
50. A Mirza, M McGuirk, TN Hockenberry, Q Wu, H Ashar, and S Black Human survivin is negatively regulated by wild-type p53 and participates in p53-dependent apoptotic pathway Oncogene 21 2002 2613 2622 (Pubitemid 34478319)
51. M Niziolek, W Korytowski, and AW. Girotti Chain-breaking antioxidant and cytoprotective action of nitric oxide in photodynamically stressed tumor cells Photochem Photobiol 78 2003 262 270
52. HS Park, J-W Wu, JH Cho, M-S Kim, S-H Huh, and K Ryoo Inhibition of apoptosis signal-regulating kinase 1 by nitric oxide through a thiol redox mechanism J Biol Chem 279 2004 7484 7490
53. HS Park, S-H Huh, M-S Kim, S-H Lee, and E-J. Choi Nitric oxide negatively regulates c-Jun N-terminal kinast/stress activated protein by means of S-nitrosylation Proc Natl Acad Sci USA 97 2000 14382 14387 (Pubitemid 32016584)
54. C-Q Li, and GN. Wogan Nitric oxide as a modulator of apoptosis Cancer Lett 226 2005 1 15 (Pubitemid 40943425)
55. N Azad, V Vallyathan, L Wang, V Tantishaiyakul, C Stehlik, SS Leonard, and Y. Rojanasakul S-nitrosylation of Bcl-2 inhibits its ubiquitin-proteosomal degradation J. Biol. Chem. 281 2006 34124 34134
56. Y-D Kwak, T Ma, S Diao, X Zhang, Y Chen, and J Hsu NO signaling and S-nitrosylation regulate PTEN inhibition in neurodegeneration Mol Neurodegener 5 2010 49 60